Immune score for predicting nasopharyngeal carcinoma metastasis and application thereof
A nasopharyngeal carcinoma and risk prediction technology, applied in the field of biomedicine, can solve the problems of lack of verification, limited number of markers, small sample size, etc., and achieve accurate prediction and good clinical drug effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0019] In order to demonstrate the technical solutions, objectives and advantages of the present invention more concisely and clearly, the present invention will be further described in detail below in conjunction with experiments and accompanying drawings.
[0020] 1. Case screening:
[0021] The inventor selected 498 cases of nasopharyngeal carcinoma patient samples (training group, n=194; verification group, n=304) through radical radiotherapy for the initial treatment of non-metastatic nasopharyngeal carcinoma, wherein 37.6% (187 / 498) of the patients received Cisplatin-based concurrent therapy, 40.4% (201 / 498) patients received induction plus concurrent chemoradiotherapy. The median follow-up time was 62.0 months (quartile IQR 26.1-60.2), and 62 of 498 patients (12.4%) developed distant metastases during the follow-up period. Tissue microarrays were made from the paraffin tissue specimens of the newly diagnosed biopsies of these 498 patients. Each patient was guaranteed t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com